http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#head
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://www.nanopub.org/nschema#hasAssertion
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://www.nanopub.org/nschema#hasProvenance
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#provenance
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://www.nanopub.org/nschema#hasPublicationInfo
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://rdf.disgenet.org/resource/gda/DGN83529e9894adcaade53aecc9f955cb31
http://semanticscience.org/resource/SIO_000628
http://identifiers.org/ncbigene/1917
http://rdf.disgenet.org/resource/gda/DGN83529e9894adcaade53aecc9f955cb31
http://semanticscience.org/resource/SIO_000628
http://linkedlifedata.com/resource/umls/id/C0019196
http://rdf.disgenet.org/resource/gda/DGN83529e9894adcaade53aecc9f955cb31
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://semanticscience.org/resource/SIO_001123
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#provenance
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://purl.org/dc/terms/description
[To determine whether baseline LDL or HDL levels and statin use affect SVR rates, we retrospectively evaluated the IDEAL (Individualized Dosing Efficacy Versus Flat Dosing to Assess Optimal Pegylated Interferon Therapy) trial, in which 3070 treatment-naive, hepatitis C virus (HCV) genotype 1-infected patients were treated for up to 48 weeks in one of the following arms: (1) peginterferon (PEG-IFN) alfa-2b at 1.5 microg/kg/week with ribavirin (RBV) at 800 to 1400 mg/day, (2) PEG-IFN alfa-2b at 1.0 microg/kg/week with RBV at 800 to 1400 mg/day, or (3) PEG-IFN alfa-2a at 180 microg/week with RBV at 1000 to 1200 mg/day.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://purl.org/ontology/wi/core#evidence
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://semanticscience.org/resource/SIO_000772
http://identifiers.org/pubmed/20568303
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://www.w3.org/ns/prov#wasDerivedFrom
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion
http://www.w3.org/ns/prov#wasGeneratedBy
http://purl.obolibrary.org/obo/ECO_0000203
http://rdf.disgenet.org/v5.0.0/void/BEFREE
http://purl.org/pav/importedOn
2017-02-19
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.obolibrary.org/obo/ECO_0000212
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#comment
Gene-disease associations inferred from text-mining the literature.
http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature
http://www.w3.org/2000/01/rdf-schema#label
DisGeNET evidence - LITERATURE
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#publicationInfo
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/dc/terms/created
2017-10-17T13:12:09+02:00
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/dc/terms/rights
http://opendatacommons.org/licenses/odbl/1.0/
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/dc/terms/rightsHolder
http://rdf.disgenet.org/v5.0.0/void/IBIGroup
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/dc/terms/subject
http://semanticscience.org/resource/SIO_000983
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/net/provenance/ns#usedData
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/authoredBy
http://orcid.org/0000-0001-5999-6269
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-7534-7661
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/authoredBy
http://orcid.org/0000-0002-9383-528X
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/authoredBy
http://orcid.org/0000-0003-1244-7654
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/createdBy
http://orcid.org/0000-0003-0169-8159
http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE
http://purl.org/pav/version
v5.0.0.0
http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf
http://purl.org/pav/version
v5.0.0